Japanese and Canadian aortic stent graft market to grow at CAGRs of nearly 60% and 20%, respectively, through 2012, according to Millennium Research Group WALTHAM, Mass., June 19
WALTHAM, Mass., June 19 /PRNewswire/ -- According to Millennium Research
Group's Japanese Markets for Peripheral Vascular (PV) Devices 2008 report, the
aortic stent graft market will increase at a compound annual growth rate
(CAGR) of nearly 60% through 2012 due to market entry of both abdominal and
thoracic stent grafts in 2006 and 2008, respectively. These new devices and a
growing physician preference for minimally invasive procedures will also be
key drivers. While growth will not be as high as in Japan, the more
established Canadian stent graft market will also expand significantly, at a
CAGR of close to 20% through 2012.
In both Canada and Japan, continued introduction of innovative stent graft
technologies will allow more patients with aortic disease to be treated using
endovascular techniques rather than surgery. For instance, in June 2008, W.L.
Gore's TAG was the first thoracic stent graft to receive regulatory approval
in Japan. The first abdominal stent grafts were approved in 2006. Procedures
will experience robust growth over the next five years as new devices are
introduced into the Japanese and Canadian markets, extending the treatable
patient population. Successful aortic repair using stent grafts has
encouraged Japanese and Canadian physicians to adopt the procedures, expanding
procedures and revenues in both countries.
"Device innovation is improving the success rates of aortic stent grafts
while also expanding the treatable patient population," says Ryan Brown,
Analyst at Millennium Research Group. "As these devices become increasingly
available in relatively underpenetrated markets, growing patient awareness of
and demand for minimally invasive aortic procedures will drive the adoption of
aortic stent grafts."
The Japanese and Canadian Markets for Peripheral Vascular Devices 2008
reports provide coverage of all key industry competitors, including Boston
Scientific, Cook Medical, Cordis, Terumo, and W.L. Gore, among others. Global
coverage of this report also includes US, Europe, Asia Pacific, and Latin
America.
About Aortic Stent Grafts
The aorta, the main artery leaving the heart, splits into two iliac
arteries that transport blood to the lower extremities. An aneurysm (the
weakening and bulging of a blood vessel or artery) directly above the iliac
bifurcation is referred to as an abdominal aortic aneurysm (AAA); one located
in the ascending aorta, aortic arch, or the descending thoracic aorta is
referred to as a thoracic aortic aneurysm (TAA). Stent grafts, tubes composed
of fabric supported by a metal mesh, are designed to fasten tightly to the
artery above and below the aneurysm. Once in place, blood passes through the
stent graft rather than pushing on the bulge of the aneurysm.
About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources, Inc.
company (www.DecisionResources.com), is the global authority on medical
technology market intelligence and a leading provider of strategic information
to the health care sector. Focused solely on the medical device,
pharmaceutical, and biotechnology industries, the company provides its clients
with the benefits of its specialized industry expertise through published
reports and customized consulting services.
All company, brand, or product names contained in this document may be
trademarks or registered trademarks of their respective holders.
For more information, contact:
Amy Krohn
Millennium Research Group
416-364-7776 x101
akrohn@mrg.net
SOURCE Millennium Research Group
